Plant-based production of biopharmaceuticals

Current Opinion in Plant Biology

Volumn 7, Issue 2, 2004, Pages 152-158

  Fischer, Rainer ^a,b   Stoger, Eva ^a   Schillberg, Stefan ^b   Christou, Paul ^b   Twyman, Richard M ^c  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b FRAUNHOFER INSTITUTE FOR MOLECULAR BIOLOGY AND APPLIED ECOLOGY IME   (Germany)

^c UNIVERSITY OF YORK   (United Kingdom)

Author keywords

glucuronidase; CaMV; Cauliflower mosaic virus; Endoplasmic reticulum; ER; GUS; Total soluble protein; TSP

Indexed keywords

BIOLOGICAL FACTOR; RECOMBINANT PROTEIN; VEGETABLE PROTEIN;

BIOREACTOR; BIOSYNTHESIS; BIOTECHNOLOGY; CHEMISTRY; METABOLISM; METHODOLOGY; PHARMACEUTICS; REVIEW; TRANSGENIC PLANT;

BIOLOGICAL FACTORS; BIOPHARMACEUTICS; BIOREACTORS; BIOTECHNOLOGY; PLANT PROTEINS; PLANTS, GENETICALLY MODIFIED; RECOMBINANT PROTEINS;

BRASSICA OLERACEA VAR. BOTRYTIS; CAULIFLOWER MOSAIC VIRUS;

EID: 1542381015     PISSN: 13695266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbi.2004.01.007     Document Type: Review

References (60)

1. Fischer R., Emans N. Molecular farming of pharmaceutical proteins. Transgenic Res. 9:2000;279-299.
2. Giddings G., Allison G., Brooks D., Carter A. Transgenic plants as factories for biopharmaceuticals. Nat. Biotechnol. 18:2000;1151-1155.
3. •].
4. •] provide recent and comprehensive reviews that explore the technological basis of pharmaceutical protein production in plants in more detail than is possible here.
5. Sala F., Rigano M.M., Barbante A., Basso B., Walmsley A.M., Castiglione S. Vaccine antigen production in transgenic plants: strategies, gene constructs and perspectives. Vaccine. 21:2003;803-808.
6. Stein K.E., Webber K.O. The regulation of biologic products derived from bioengineered plants. Curr. Opin. Biotechnol. 12:2001;308-311.
7. Miele L. Plants as bioreactors for biopharmaceuticals: regulatory considerations. Trends Biotechnol. 15:1997;45-50.
8. Stoger E., Sack M., Perrin Y., Vaquero C., Torres E., Twyman R.M., Christou P., Fischer R. Practical considerations for pharmaceutical antibody production in different crop systems. Mol. Breed. 9:2000;149-158.
9. Kapusta J., Modelska A., Figlerowicz M., Pniewski T., Letellier M., Lisowa O., Yusibov V., Koprowski H., Plucienniczak A., Legocki A.B. A plant-derived edible vaccine against hepatitis B virus. FASEB J. 13:1999;1796-1799.
10. D'Aoust MA, Lerouge P, Busse U, Bilodeau P, Trépanier S, Gomord V, Faye L, Vézina LP: Efficient and reliable production of pharmaceuticals in alfalfa. In Molecular Farming: Plant-made Pharmaceuticals and Technical Proteins. Edited by Fischer R, Schillberg S. New York: John Wiley & Sons; in press.
11. Larrick J.W., Thomas D.W. Producing proteins in transgenic plants and animals. Curr. Opin. Biotechnol. 12:2001;411-418.
12. Hood E.E. From green plants to industrial enzymes. Enzyme Microb. Technol. 30:2002;279-283.
13. Hood E.E., Witcher D.R., Maddock S., Meyer T., Baszczynski C., Bailey M., Flynn P., Register J., Marshall L., Bond D.et al. Commercial production of avidin from transgenic maize: characterization of transformant, production, processing, extraction and purification. Mol. Breed. 3:1997;291-306.
14. Witcher D.R., Hood E.E., Peterson D., Bailey M., Bond D., Kusnadi A., Evangelista R., Nikolov Z., Wooge C., Mehigh R.et al. Commercial production of β-glucuronidase (GUS): a model system for the production of proteins in plants. Mol. Breed. 4:1998;301-312.
15. Lamphear B.J., Streatfield S.J., Jilka J.A., Brooks C.A., Barker D.K., Turner D.D., Delaney D.E., Garcia M., Wiggins B., Woodard S.L.et al. Delivery of subunit vaccines in maize seed. J. Control Release. 85:2002;169-180.
16. Hood E.E., Woodard S.L., Horn M.E. Monoclonal antibody manufacturing in transgenic plants - myths and realities. Curr. Opin. Biotechnol. 13:2002;630-635.
17. Azzoni A.R., Kusnadi A.R., Miranda E.A., Nikolov Z.L. Recombinant aprotinin produced in transgenic corn seed: extraction and purification studies. Biotechnol. Bioeng. 80:2002;268-276.
18. Daniell H., Streatfield S.J., Wycoff K. Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends. Plant Sci. 6:2001;219-226.
19. Farran I., Sanchez-Serrano J.J., Medina J.F., Prieto J., Mingo-Castel A.M. Targeted expression of human serum albumin to potato tubers. Transgenic Res. 11:2002;337-346.
20. Yu J., Langridge W. Expression of rotavirus capsid protein VP6 in transgenic potato and its oral immunogenicity in mice. Transgenic. Res. 12:2003;163-169.
21. Biemelt S., Sonnewald U., Gaimbacher P., Willmitzer L., Muller M. Production of human papillomavirus type 16 viral-like particles in transgenic plants. J. Virol. 77:2003;9211-9220.
22. Ohya K., Itchoda N., Ohashi K., Onuma M., Sugimoto C., Matsumura T. Expression of biologically-active human tumor necrosis factor-alpha in transgenic potato plant. J. Interferon Cytokine Res. 22:2002;371-378.
23. De Wilde C., Peeters K., Jacobs A., Peck I., Depicker A. Expression of antibodies and Fab fragments in transgenic potato plants: a case study for bulk production in crop plants. Mol. Breed. 9:2002;271-282.
24. Schunmann P.H.D., Coia G., Waterhouse P.M. Biopharming the SimpliRED™ HIV diagnostic reagent in barley, potato and tobacco. Mol. Breed. 9:2002;113-121.
25. Mayfield S.P., Franklin S.E., Lerner R.A. Expression and assembly of a fully active antibody in algae. Proc. Natl. Acad. Sci. USA. 100:2003;438-442. The authors describe the production of a large single-chain antibody in the chloroplasts of Chlamydomonas reinhardtii, and demonstrate that the antibody forms dimers, accumulates in a soluble form, and binds to its target antigen (herpes simplex virus glycoprotein D) in enzyme-linked immunosorbent assays (ELISAs).
26. Gasdaska J.R., Spencer D., Dickey L. Advantages of therapeutic protein production in the aquatic plant Lemna. Bioprocess J. 2:2003;49-56.
27. Kapila J., DeRycke R., VanMontagu M., Angenon G. An Agrobacterium- mediated transient gene expression system for intact leaves. Plant Sci. 122:1997;101-108.
28. Vaquero C., Sack M., Schuster F., Finnern R., Drossard J., Schumann D., Reimann A., Fischer R. A carcinoembryonic antigen-specific diabody produced in tobacco. FASEB J. 16:2002;408-410.
29. Kathuria S., Sriraman R., Nath R., Sack M., Pal R., Artsaenko O., Talwar G.P., Fischer R., Finnern R. Efficacy of plant-produced recombinant antibodies against HCG. Hum Reprod. 17:2002;2054-2061.
30. Voinnet O., Rivas S., Mestre P., Baulcombe D. An enhanced transient expression system in plants based on suppression of gene silencing by the p19 protein of tomato bushy stunt virus. Plant J. 33:2003;949-956. The authors show that co-expression of a target protein and the p19 protein from tomato bushy stunt virus, a known suppressor of post-transcriptional gene silencing, results in a greater than 50-fold increase in the level of target proteins produced in agroinfiltrated leaves. The target proteins could be purified from as little as 100 mg of leaf tissue.
31. McCormick A.A., Reinl S.J., Cameron T.I., Vojdani F., Fronefield M., Levy R., Tuse D. Individualized human scFv vaccines produced in plants: humoral anti-idiotype responses in vaccinated mice confirm relevance to the tumor Ig. J. Immunol. Methods. 278:2003;95-104.
32. Verch T., Yusibov V., Koprowski H. Expression and assembly of a full-length monoclonal antibody in plants using a plant virus vector. J. Immunol. Methods. 220:1998;69-75.
33. Maliga P. Engineering the plastid genome of higher plants. Curr. Opin. Plant Biol. 5:2002;164-172.
34. Daniell H., Khan M.S., Allison L. Milestones in chloroplast genetic engineering: an environmentally friendly era in biotechnology. Trends Plant Sci. 7:2002;84-91.
35. •], demonstrate the extraordinary expression levels that can be achieved when recombinant proteins are expressed in transgenic chloroplasts.
36. •].
37. •].
38. Ruf S., Hermann M., Berger I.J., Carrer H., Bock R. Stable genetic transformation of tomato plastids and expression of a foreign protein in fruit. Nat Biotechnol. 19:2001;870-875.
39. Shadwick FS, Doran PM: Foreign protein expression using plant cell suspension and hairy root cultures. In Molecular Farming: Plant-made Pharmaceuticals and Technical Proteins. Edited by Fischer R, Schillberg S. New York: John Wiley & Sons; in press.
40. Kwon T.H., Kim Y.S., Lee J.H., Yang M.S. Production and secretion of biologically active human granulocyte-macrophage colony stimulating factor in transgenic tomato suspension cultures. Biotechnol. Lett. 25:2003;1571-1574.
41. Shin Y.J., Hong S.Y., Kwon T.H., Jang Y.S., Yang M.S. High level of expression of recombinant human granulocyte-macrophage colony stimulating factor in transgenic rice cell suspension culture. Biotechnol. Bioeng. 82:2003;778-783.
42. Banerjee S., Shang T.Q., Wilson A.M., Moore A.L., Strand S.E., Gordon M.P., Doty S.L. Expression of functional mammalian P450 in hairy root cultures. Biotechnol. Bioeng. 77:2002;462-466.
43. Smith M.L., Mason H.S., Shuler M.L. Hepatitis B surface antigen (HBsAg) expression in plant cell culture: kinetics of antigen accumulation in batch culture and its intracellular form. Biotechnol. Bioeng. 80:2002;812-822.
44. Schillberg S., Fischer R., Emans N. Molecular farming of recombinant antibodies in plants. Cell. Mol. Life Sci. 60:2003;433-445.
45. Padidam M. Chemically regulated gene expression in plants. Curr. Opin. Plant Biol. 6:2003;169-177.
46. Kim K.Y., Kwon S.Y., Lee H.S., Hur Y., Bang J.W., Kwak S.S. A novel oxidative stress-inducible peroxidase promoter from sweet potato: molecular cloning and characterization in transgenic tobacco plants and cultured cells. Plant Mol. Biol. 51:2003;831-838.
47. De Jaeger G., Scheffer S., Jacobs A., Zambre M., Zobell O., Goossens A., Depicker A., Angenon G. Boosting heterologous protein production in transgenic dicotyledonous seeds using Phaseolus vulgaris regulatory sequences. Nat. Biotechnol. 20:2002;1265-1268. A novel seed-specific promoter from the common bean, Phaseolus vulgaris,was used to express a recombinant antibody in Arabidopsis thaliana. When the bean promoter was used, the antibody accumulated to levels nearly 40-fold higher than those achieved with the CaMV 35S promoter, and the antibody remained functional and able to bind its target antigen.
48. Wang E.M., Gan S.S., Wagner G.J. Isolation and characterization of the CYP71D16 trichome-specific promoter from Nicotiana tabacum L. J. Exp. Bot. 53:2002;1891-1897.
49. Drake P.M.W., Chargeleuge D.M., Vine N.D., van Dolleweerd C.J., Obregon P., Ma J.K.C. Rhizosecretion of a monoclonal antibody protein complex from transgenic tobacco roots. Plant Mol. Biol. 52:2003;233-241. This report is notable because monoclonal antibodies, which are large molecules, were successfully secreted from the roots of transgenic tobacco plants growing in hydroponic culture medium. Yields of up to 11.7 μg antibody per gram of dry root mass per day were achieved.
50. Schillberg S., Zimmermann S., Voss A., Fischer R. Apoplastic and cytosolic expression of full-size antibodies and antibody fragments in Nicotiana tabacum. Transgenic. Res. 8:1999;255-263.
51. Schouten A., Roosien J., Bakker J., Schots A. Formation of disulfide bridges by a single-chain Fv antibody in the reducing ectopic environment of the plant cytosol. J. Biol. Chem. 277:2002;19339-19345.
52. Nuttall J., Vine N., Hadlington J.L., Drake P., Frigerio L., Ma J.K.C. ER-resident chaperone interactions with recombinant antibodies in transgenic plants. Eur. J. Biochem. 269:2002;6042-6051.
53. Conrad U., Fiedler U. Compartment-specific accumulation of recombinant immunoglobulins in plant cells: an essential tool for antibody production and immunomodulation of physiological functions and pathogen activity. Plant Mol. Biol. 38:1998;101-109.
54. Ko K., Tekoah Y., Rudd P.M., Harvey D.J., Dwek R.A., Spitsin S., Hanlon C.A., Rupprecht C., Dietzschold B., Golovkin M., Koprowski H. Function and glycosylation of plant-derived antiviral monoclonal antibody. Proc. Natl. Acad. Sci. USA. 100:2003;8013-8018.
55. Ramirez N., Rodriguez M., Ayala M., Cremata J., Perez M., Martinez A., Linares M., Hevia Y., Paez R., Valdes R.et al. Expression and characterization of an anti-hepatitis B surface antigen glycosylated mouse antibody in transgenic tobacco plants, and its use in the immunopurification of its target antigen. Biotechnol. Appl. Biochem. 38:2003;223-230.
56. Murray C., Sutherland P.W., Phung M.M., Lester M.T., Marshall R.K., Christeller J.T. Expression of biotin-binding protein, avidin and streptavidin, in plant tissues using plant vacuolar targeting sequences. Transgenic Res. 11:2002;199-214.
57. Schillberg S., Zimmermann S., Findlay K., Fischer R. Plasma membrane display of anti-viral single chain Fv fragments confers resistance to tobacco mosaic virus. Mol. Breed. 6:2000;317-326.
58. Leelavathi S., Reddy V.S. Chloroplast expression of His-tagged GUS fusions: a general strategy to overproduce and purify foreign proteins using transplastomic plants as bioreactors. Mol. Breed. 11:2003;49-58.
59. Crofcheck C., Loiselle M., Weekly J., Maiti I., Pattanaik S., Bummer P.M., Jayt M. Histidine-tagged protein recovery from tobacco extract by foam fractionation. Biotechnol. Prog. 19:2003;680-682.
60. Morassutti C., De Amicis F., Skerlavaj B., Zanetti M., Marchetti S. Production of a recombinant antimicrobial peptide in transgenic plants using a modified VMA intein expression system. FEBS Lett. 519:2002;141-146. In this work, transgenic tobacco plants were used to produce a mammalian antimicrobial peptide called SMAP-29. The peptide was expressed as a fusion with a modified vacuolar ATPase intein. Purification of the peptide was achieved by exploiting the self-cleaving activity of the intein. Correct processing was demonstrated and the purified peptide retained its antimicrobial activity.